Safety and Pharmacokinetic Study of HRS-1893 Tablets in Subjects With Mild and Moderate Renal Insufficiency and Healthy Subjects
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs HRS-1893 (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Pharmacokinetics
- Sponsors Shandong Suncadia Medicine
- 20 Jan 2025 New trial record